Maria A Corcorran,Nina Kim
Maria A Corcorran
Hepatitis B virus (HBV) infection is common among people with HIV owing to shared modes of viral transmission. Compared with individuals with HBV infection alone, people with HIV/HBV coinfection experience an accelerated progression of live...
Providing gender-affirming care to transgender and gender-diverse individuals with and at risk for HIV [0.03%]
向HIV感染者及易感者的性别多样人群提供性别肯定的医疗护理
Olivia T Van Gerwen,Jill S Blumenthal
Olivia T Van Gerwen
Transgender and gender-diverse populations have unique medical and psychosocial needs. It is important that clinicians address these needs with a gender-affirming approach in all aspects of health care for these populations. Given the signi...
Heidi M Torres,Grant Ellsworth,Jason Zucker et al.
Heidi M Torres et al.
The 2022 outbreak of monkeypox virus infection has expanded far beyond regions in which the disease was previously endemic. Monkeypox has a wide range of manifestations, some of which are unique to this outbreak. Novel clinical presentation...
Annemarie M Wensing,Vincent Calvez,Francesca Ceccherini-Silberstein et al.
Annemarie M Wensing et al.
The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure i...
Kenneth E Sherman,David L Thomas
Kenneth E Sherman
Despite substantial advances in the field, liver disease morbidity and mortality remain serious issues among people with HIV. The causes of liver disease are often multifactorial and include hepatitis viruses, hepatic steatosis and oxidativ...
Hasiya Eihuri Yusuf,David Griffith,Allison Lorna Agwu
Hasiya Eihuri Yusuf
Adolescents with HIV are growing into adulthood and are at risk for comorbidities. Comorbidities in adolescents often go unrecognized, increasing morbidity and mortality, and contributing to poorer outcomes for youth with HIV. Youth with pe...
CROI 2022: tuberculosis and infectious complications in persons With HIV [0.03%]
CROI 2022：HIV感染者中的结核病和感染并发症
Andrew D Kerkhoff,Diane V Havlir
Andrew D Kerkhoff
Early treatment of anal high-grade squamous intraepithelial lesions compared with active monitoring reduced the risk of anal cancer by 57% in persons with HIV in a landmark randomized trial of 4446 participants. In a multi- country randomiz...
Randomized Controlled Trial
Topics in antiviral medicine. 2022 Oct-Nov;30(3):528-536. DOI: 2022
CROI 2022: metabolic and other complications of HIV infection or COVID-19 [0.03%]
CROI 2022:HIV感染或COVID-19的代谢和其他并发症
Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Comorbid conditions have a major impact on the health, quality of life, and survival of people with HIV, particularly as this population ages. The 2022 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent scienc...
CROI 2022: advances in antiviral therapy for HIV, COVID-19, and viral hepatitis [0.03%]
CROI 2022: 抗病毒治疗在HIV、COVID-19和病毒性肝炎方面的进展
Shauna H Gunaratne,Hong-Van Tieu,Timothy J Wilkin et al.
Shauna H Gunaratne et al.
The 2022 Conference on Retroviruses and Opportunistic Infections provided a rich source of new data and comprehensive reviews on antiviral therapy. For COVID-19, intramuscular sotrovimab was noninferior to intravenous sotrovimab, serostatus...
CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens [0.03%]
CROI 2022：HIV-1、SARS-CoV-2和其他病原体引起神经并发症
Albert M Anderson,Scott L Letendre,Beau M Ances
Albert M Anderson
The 2022 Conference on Retroviruses and Opportunistic Infections featured new and important findings about the neurologic complications of HIV-1, COVID-19, and other infections. Long-term analyses identified that cognitive decline over time...
Randomized Controlled Trial
Topics in antiviral medicine. 2022 Oct-Nov;30(3):475-489. DOI: 2022